Skip to content

Can immunotherapy cause headaches? What patients need to know

5 min read

Up to 6% of patients receiving certain immune checkpoint inhibitors experience neurological side effects, including headaches. Yes, can immunotherapy cause headaches is a common question, and the answer is that they can be a side effect of treatment, ranging from mild discomfort to signs of a more serious condition.

Quick Summary

Immunotherapy can cause headaches through various mechanisms, including inflammatory responses, direct neurotoxicity, and endocrine inflammation. The severity and type of headache vary depending on the specific treatment and individual factors.

Key Points

  • Headaches are a documented side effect: Immunotherapy, particularly treatments like CAR T-cell therapy and immune checkpoint inhibitors (ICIs), can cause headaches as a known side effect due to immune activation and inflammation.

  • Multiple underlying causes exist: Headaches can result from Cytokine Release Syndrome (CRS), Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS), or endocrine inflammation such as hypophysitis.

  • Severity depends on the treatment: The risk and severity of headaches can vary based on the specific type of immunotherapy, with CAR T-cell therapy associated with higher rates of neurotoxicity than some ICIs.

  • Prompt medical reporting is essential: Patients should report any new, worsening, or severe headaches to their care team, especially if accompanied by other neurological or flu-like symptoms.

  • Management is tailored to the cause: Treatment can range from supportive care and over-the-counter medication for mild symptoms to corticosteroids for severe inflammation, or even temporary cessation of the immunotherapy.

  • Not always a sign of serious illness: While some headaches indicate severe neurotoxicity, others are simply part of mild, flu-like symptoms resulting from the treatment's effect on the immune system.

In This Article

Immunotherapy represents a powerful class of cancer treatments that leverage the body's own immune system to fight disease. However, activating the immune system can lead to side effects, including headaches. The nature of these headaches can vary significantly depending on the specific type of immunotherapy and the underlying immune-related adverse event (irAE) causing them. Understanding the potential causes and how to manage them is crucial for patients undergoing this therapy.

The Mechanisms Behind Immunotherapy-Induced Headaches

Headaches triggered by immunotherapy are not caused by the cancer itself but are a consequence of the activated immune response. This immune dysregulation can lead to inflammation that affects different parts of the body, including the central nervous system. Several mechanisms have been identified as potential drivers of headaches in immunotherapy patients.

Systemic Inflammation and Cytokine Release Syndrome (CRS)

Many immunotherapies work by stimulating immune cells to release cytokines, which are small proteins that boost the immune response. A rapid and overwhelming release of these cytokines can lead to a condition known as Cytokine Release Syndrome (CRS). CRS is particularly common with CAR T-cell therapy and can cause flu-like symptoms, which frequently include fever, fatigue, chills, body aches, and headaches. These headaches can be a result of the widespread inflammation associated with this syndrome.

Direct Neurological Inflammation

In more severe cases, the immune response can directly target or inflame the nervous system. This can lead to a syndrome called Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS), primarily seen with CAR T-cell therapy, where headaches are a key symptom along with confusion and seizures. Rarer but more serious complications, such as encephalitis (brain inflammation) and meningitis (inflammation of the membranes around the brain and spinal cord), can also be triggered by immune checkpoint inhibitors (ICIs) and present with severe headaches, fever, and altered consciousness.

Endocrine System Inflammation (Hypophysitis)

Some immunotherapies, especially certain immune checkpoint inhibitors like ipilimumab, can cause inflammation of the pituitary gland, a condition known as hypophysitis. The pituitary gland regulates many hormones, and its inflammation can cause a range of symptoms, including persistent headaches, fatigue, and other hormonal imbalances. These headaches are typically one of the presenting signs of the condition and can be severe if not treated.

Types of Immunotherapy and Associated Headache Risks

The risk and severity of headaches can differ depending on the type of immunotherapy being used.

  • Immune Checkpoint Inhibitors (ICIs): While neurological side effects are relatively rare (occurring in 0.1% to 12% of patients depending on the drug or combination), they can still include headaches. Certain ICIs, especially those targeting CTLA-4, are more frequently associated with hypophysitis and its related headaches.
  • CAR T-cell Therapy: This form of immunotherapy has a higher reported rate of neurological complications, with some studies reporting rates as high as 48%. Headaches in these cases are often linked to CRS or ICANS, which require careful monitoring and management.
  • Other Immunotherapies: Other non-specific immunotherapies, such as monoclonal antibodies, can also induce flu-like symptoms and headaches due to their effect on the immune system.

Managing Headaches from Immunotherapy

The management strategy for immunotherapy-related headaches depends on the underlying cause and severity. It is always critical to report any new or worsening headaches to your healthcare team promptly.

Non-Pharmacological Management

For mild, flu-like headaches, several non-medicinal approaches can provide relief:

  • Cool compresses: Applying a cool cloth to the forehead or neck can help soothe throbbing pain.
  • Massage: Gentle massage of the head, neck, and shoulders can relieve tension headaches.
  • Hydration: Staying well-hydrated is important for overall health and can sometimes alleviate headache symptoms, especially those related to flu-like side effects.
  • Rest: Balancing rest and activity can help manage fatigue and associated headaches.

Medical Management

Your care team will determine the appropriate medical treatment based on the cause and severity of the headache.

  • Over-the-counter pain relievers: For mild headaches, medications like acetaminophen (Tylenol) may be recommended. It is important to consult your healthcare provider before taking any medication, including NSAIDs like ibuprofen or aspirin, as they may be contraindicated depending on your condition.
  • Corticosteroids: For severe inflammatory conditions like encephalitis or severe hypophysitis, high-dose corticosteroids are often prescribed to suppress the immune response.
  • Hormone Replacement Therapy: If hypophysitis is the cause of the headache, hormone replacement therapy may be necessary to correct the resulting hormonal deficiencies.
  • Immunotherapy cessation: In severe or persistent cases, the healthcare team may temporarily or permanently stop the immunotherapy treatment.

Immunotherapy vs. Chemotherapy Headaches: A Comparison

While both immunotherapy and chemotherapy can cause headaches, the mechanisms and characteristics often differ.

Feature Immunotherapy Headaches Chemotherapy Headaches
Mechanism Caused by immune system activation and inflammation (e.g., CRS, ICANS, hypophysitis). Often caused by direct toxicity to rapidly dividing cells, electrolyte imbalances, or other medications.
Onset Can appear during treatment or months after treatment has ended due to persistent immune-related side effects. Tend to occur more immediately during or shortly after treatment cycles.
Severity Varies widely from mild flu-like symptoms to severe, progressive neurological events. Also varies, but can be exacerbated by other side effects like nausea and dehydration.
Associated Symptoms Often accompanied by flu-like symptoms, rash, fatigue, or neurological changes like confusion. Associated with other common chemotherapy side effects like nausea, hair loss, and fatigue.

When to Contact Your Healthcare Team

Always inform your cancer care team about any new or unusual symptoms. Immediate medical attention is needed for the following:

  • A headache described as “the worst headache of your life”.
  • A new or worsening headache that doesn't improve with rest or standard care.
  • Headaches accompanied by a fever or stiff neck.
  • Headaches with other neurological symptoms like confusion, weakness, vision changes, or seizures.

Conclusion

While the prospect of headaches during cancer treatment can be concerning, it is important to remember that they are a manageable side effect of immunotherapy. They are an indicator of the body’s activated immune response and often a sign of inflammation rather than a disease progression. By working closely with your healthcare team and understanding the potential causes, you can effectively manage these symptoms and continue your treatment journey. Open communication with your doctor and care team is the most effective way to ensure proper diagnosis and treatment for any adverse events, including headaches, throughout your immunotherapy.

Managing toxicities associated with immune checkpoint inhibitors

Frequently Asked Questions

The feeling can vary. It can present as a throbbing head pain, a dull ache, or feel like a tension headache. In more severe cases linked to inflammation, it might be an intense, unusual, or persistent headache.

Headaches can be acute, lasting for hours or days and then stopping, or chronic, lasting 15 or more days a month for several months. Duration depends on the underlying cause and the specific type of immunotherapy.

Over-the-counter pain relievers like acetaminophen (Tylenol) may be recommended for mild headaches, but it is crucial to consult your healthcare provider first. They can advise on the safest options and determine if the headache indicates a more serious issue requiring different management.

Headaches are a side effect and not a reliable indicator that immunotherapy is effectively fighting cancer. They signify an immune reaction, which is the goal of the treatment, but do not directly correlate with tumor response.

ICANS, or Immune Effector Cell-Associated Neurotoxicity Syndrome, is a neurological toxicity linked to CAR T-cell therapy. It includes symptoms like headache, confusion, seizures, and difficulty speaking and is caused by the immune system's overreaction.

A headache can be a sign of both mild and serious side effects. While it can be part of benign flu-like symptoms, a severe, unusual, or worsening headache, especially with other neurological symptoms, can signal a serious inflammatory condition like encephalitis and requires immediate medical attention.

Immunotherapy can trigger or worsen existing migraines in susceptible individuals. Changes in lifestyle and stress associated with a cancer diagnosis can also contribute. Some immunotherapy-induced headaches may resemble migraines in their presentation.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.